![](/img/cover-not-exists.png)
Zalutumumab plus best supportive care versus best supportive care alone in patients with recurrent or metastatic squamous-cell carcinoma of the head and neck after failure of platinum-based chemotherapy: an open-label, randomised phase 3 trial
Jean-Pascal Machiels, Somasundaram Subramanian, Agnes Ruzsa, Gabor Repassy, Igor Lifirenko, Annika Flygare, Per Sørensen, Tina Nielsen, Steen Lisby, Paul MJ ClementVolume:
12
Year:
2011
Language:
english
DOI:
10.1016/s1470-2045(11)70034-1
File:
PDF, 315 KB
english, 2011